Catalyst Wire Dossier Catalyst Wire Dossier

Budoprutug

Budoprutug · Climb Bio, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Budoprutug, covering 2026-03-13 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy [Phase 2]

See pricing